Filing Flows › Rani Therapeutics Holdings (RANI) › Q1 2026 › vs Q4 2025
Rani Therapeutics Holdings (RANI) Q1 2026 vs Q4 2025 (quarter over quarter)
Rani Therapeutics Holdings's revenue rose $247K (+17%) from $1.5M in Q4 2025 to $1.7M in Q1 2026.
Rani Therapeutics Holdings, Q1 2026: revenue $1.7M (+893% year over year), operating margin -488.2%, net loss $8.0M, operating cash flow −$6.5M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.7M | $1.5M | $247K | +17% |
| Other income, net | $324K | −$539K | $863K | — |
| Net loss | $8.0M | $9.1M | −$1.1M | -12% |
| Costs & expenses | $10.0M | $10.5M | −$488K | -5% |
| Operating costs | $10.0M | $10.0M | $51K | +0.5% |
| Research & development | $5.2M | $4.9M | $252K | +5% |
| General & admin | $4.9M | $5.1M | −$201K | -4% |
| Operating cash sources | $8.7M | $2.1M | $6.6M | +310% |
| Depreciation & amortization | $161K | $186K | −$25K | -13% |
| Share-based compensation | $2.1M | $2.2M | −$154K | -7% |
| Cash used in operations | $6.5M | −$294K | $6.8M | — |
| Net loss absorbed | $8.0M | $9.1M | −$1.1M | -12% |
| Working capital & other | $727K | −$6.9M | $7.7M | — |
Questions
How much did Rani Therapeutics Holdings's revenue grow quarter over quarter in Q1 2026?
Rani Therapeutics Holdings's revenue rose $247K (+17%) from $1.5M in Q4 2025 to $1.7M in Q1 2026.